[Insulin resistance in myotonic dystrophy].
Kono
Shigeo
S
Diabetes Center, Kyoto National Hospital.
D002839:Chromans / Q000627:therapeutic use; D006801:Humans; D006946:Hyperinsulinism / Q000209:etiology; D007333:Insulin Resistance; D007334:Insulin-Like Growth Factor I / Q000627:therapeutic use; D009223:Myotonic Dystrophy / Q000150:complications / Q000188:drug therapy / Q000235:genetics; D065636:Myotonin-Protein Kinase; D011494:Protein Kinases / Q000235:genetics; D017346:Protein Serine-Threonine Kinases; D013844:Thiazoles / Q000627:therapeutic use; D045162:Thiazolidinediones; D018911:Trinucleotide Repeats; D000077288:Troglitazone
D002839:Chromans; C585517:DMPK protein, human; D013844:Thiazoles; D045162:Thiazolidinediones; D007334:Insulin-Like Growth Factor I; D011494:Protein Kinases; D065636:Myotonin-Protein Kinase; D017346:Protein Serine-Threonine Kinases; D000077288:Troglitazone